Akebia Therapeutics Current Ratio 2013-2019 | AKBA

Akebia Therapeutics current ratio from 2013 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Akebia Therapeutics Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-09-30 $0.30B $0.22B 1.34
2019-06-30 $0.32B $0.19B 1.71
2019-03-31 $0.35B $0.20B 1.71
2018-12-31 $0.47B $0.27B 1.76
2018-09-30 $0.40B $0.18B 2.24
2018-06-30 $0.41B $0.16B 2.48
2018-03-31 $0.44B $0.15B 2.89
2017-12-31 $0.36B $0.14B 2.54
2017-09-30 $0.33B $0.15B 2.21
2017-06-30 $0.33B $0.18B 1.83
2017-03-31 $0.26B $0.13B 1.91
2016-12-31 $0.30B $0.11B 2.59
2016-09-30 $0.17B $0.03B 6.32
2016-06-30 $0.19B $0.02B 9.20
2016-03-31 $0.22B $0.01B 16.37
2015-12-31 $0.14B $0.01B 11.88
2015-09-30 $0.16B $0.01B 11.21
2015-06-30 $0.16B $0.01B 26.25
2015-03-31 $0.10B $0.01B 11.62
2014-12-31 $0.11B $0.01B 16.05
2014-09-30 $0.12B $0.01B 18.38
2014-06-30 $0.13B $0.01B 26.43
2014-03-31 $0.13B $0.01B 21.84
2013-12-31 $0.03B $0.00B 8.57
2013-09-30 $0.00B 0.00
2013-06-30 $0.00B 0.00
2013-03-31 $0.00B 0.00
2012-12-31 $0.00B $0.01B 0.46
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.412B $0.208B
Akebia Therapeutics Inc. is a biopharmaceutical company. It focuses on the development and commercialization of proprietary therapeutics based on hypoxia inducible factor biology for patients with kidney disease. Akebia Therapeutics, Inc. is headquartered in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Takeda Pharmaceutical (TAK) Japan $63.901B 10.10
Zoetis (ZTS) United States $57.261B 34.25
Astellas Pharma (ALPMY) Japan $31.581B 15.77
Eisai (ESALY) Japan $20.389B 39.31
UCB SA (UCBJF) Belgium $15.697B 0.00
Merck (MKGAF) Germany $15.446B 21.08
Grifols, S.A (GRFS) Spain $15.250B 19.46
Neurocrine Biosciences (NBIX) United States $10.476B 494.57
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
IPSEN SA ADR (IPSEY) France $8.886B 0.00
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.638B 0.00
Ionis Pharmaceuticals (IONS) United States $8.493B 17.20
Jazz Pharmaceuticals (JAZZ) Ireland $8.069B 10.31
Sage Therapeutics (SAGE) United States $7.865B 0.00
Catalent (CTLT) United States $7.542B 30.68
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.263B 0.00
Orion OYJ (ORINY) Finland $5.849B 30.12
STADA ARZNEIMI (STDAF) Germany $5.375B 0.00
Hypermarcas (HYPMY) Brazil $5.203B 18.70
Arrowhead Pharmaceuticals (ARWR) United States $4.652B 106.65
United Therapeutics (UTHR) United States $4.099B 0.00
Nektar Therapeutics (NKTR) United States $3.539B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.503B 12.80
FibroGen (FGEN) United States $3.304B 97.10
Evotec AG (EVTCY) Germany $3.079B 50.38
PTC Therapeutics (PTCT) United States $2.643B 0.00
Tilray (TLRY) Canada $2.249B 0.00
Portola Pharmaceuticals (PTLA) United States $2.227B 0.00
Heron Therapeutics (HRTX) United States $2.198B 0.00
Xencor (XNCR) United States $2.180B 66.26
Zogenix (ZGNX) United States $2.034B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.874B 59.75
Pacira Pharmaceuticals (PCRX) United States $1.839B 54.42
USANA Health Sciences (USNA) United States $1.540B 16.43
Corcept Therapeutics (CORT) United States $1.482B 18.01
Enanta Pharmaceuticals (ENTA) United States $1.250B 28.61
CLINIGEN GP (CLIGF) United Kingdom $1.244B 0.00
Radius Health (RDUS) United States $1.081B 0.00
Endo (ENDP) Ireland $1.032B 1.90
ArQule (ARQL) United States $1.026B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.016B 0.00
Karyopharm Therapeutics (KPTI) United States $1.011B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.977B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.909B 6.20
Aerie Pharmaceuticals (AERI) United States $0.852B 0.00
TherapeuticsMD (TXMD) United States $0.719B 0.00
Collegium Pharmaceutical (COLL) United States $0.644B 0.00
Flexion Therapeutics (FLXN) United States $0.643B 0.00
Translate Bio (TBIO) United States $0.643B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.587B 0.00
Organogenesis Holdings (ORGO) United States $0.575B 0.00
Concordia (CXRXF) Canada $0.552B 0.00
ImmunoGen (IMGN) United States $0.490B 0.00
ChemoCentryx (CCXI) United States $0.485B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.468B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.457B 0.00
Dermira (DERM) United States $0.451B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.448B 54.38
Siga Technologies (SIGA) United States $0.410B 9.37
Ardelyx (ARDX) United States $0.403B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.396B 17.09
Recro Pharma (REPH) United States $0.396B 0.00
OptiNose (OPTN) United States $0.391B 0.00
Harpoon Therapeutics (HARP) United States $0.378B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.375B 0.00
Molecular Templates (MTEM) United States $0.373B 0.00
Indivior (INVVY) United States $0.367B 1.33
Lannett Co Inc (LCI) United States $0.357B 4.15
DURECT (DRRX) United States $0.342B 0.00
Innate Pharma SA (IPHYF) France $0.338B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.332B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.308B 0.00
Rafael Holdings (RFL) United States $0.289B 0.00
GlycoMimetics (GLYC) United States $0.231B 0.00
KalVista Pharmaceuticals (KALV) United States $0.229B 0.00
Calithera Biosciences (CALA) United States $0.226B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.217B 0.00
Xeris Pharmaceuticals (XERS) United States $0.209B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.203B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.190B 0.00
Nature's Sunshine Products (NATR) United States $0.187B 32.20
Taiwan Liposome (TLC) Taiwan $0.163B 0.00
Concert Pharmaceuticals (CNCE) United States $0.160B 0.00
Jounce Therapeutics (JNCE) United States $0.159B 2.12
Aquestive Therapeutics (AQST) United States $0.155B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.153B 0.00
CV Sciences (CVSI) United States $0.144B 0.00
Ocular Therapeutix (OCUL) United States $0.142B 0.00
CannTrust Holdings (CTST) Canada $0.135B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.132B 0.00
MEI Pharma (MEIP) United States $0.132B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.128B 0.00
Redhill Biopharma (RDHL) Israel $0.126B 0.00
IMV INC (IMV) Canada $0.119B 0.00
Cardiome Pharma (CORV) Canada $0.111B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.093B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.088B 0.00
Majesco Entertainment (PTE) United States $0.084B 0.00
MediWound (MDWD) Israel $0.081B 0.00
Otonomy (OTIC) United States $0.079B 0.00
Neos Therapeutics (NEOS) United States $0.076B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.073B 21.77
Adamis Pharmaceuticals (ADMP) United States $0.066B 0.00
Capnia (SLNO) United States $0.066B 0.00
Aclaris Therapeutics (ACRS) United States $0.065B 0.00
SCYNEXIS (SCYX) United States $0.065B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.065B 0.00
Infinity Pharmaceuticals (INFI) United States $0.064B 0.00
Champions Oncology (CSBR) United States $0.063B 0.00
Pharmaxis (PXSLY) Australia $0.061B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.060B 0.00
Generex Biotechnology (GNBT) United States $0.060B 0.00
Genocea Biosciences (GNCA) United States $0.058B 0.00
Natural Alternatives (NAII) United States $0.057B 14.21
Nivalis Therapeutics (ALPN) United States $0.057B 0.00
Medicure (MCUJF) Canada $0.056B 0.00
AgeX Therapeutics (AGE) United States $0.054B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.054B 0.00
Novan (NOVN) United States $0.053B 0.00
RENEURON GP (RNUGF) United Kingdom $0.052B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.050B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.045B 0.00
ElectroCore (ECOR) United States $0.045B 0.00
CTI BioPharma (CTIC) United States $0.042B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.041B 0.00
Forward Pharma (FWP) Denmark $0.041B 0.00
Mannatechorporated (MTEX) United States $0.037B 0.00
Mast Therapeutics (SVRA) United States $0.037B 0.00
India Globalization Capital (IGC) United States $0.034B 0.00
Opexa Therapeutics (ACER) United States $0.034B 0.00
Biomerica (BMRA) United States $0.028B 0.00
Jaguar Animal Health (JAGX) United States $0.028B 0.00
IsoRay (ISR) United States $0.028B 0.00
PharmAthene (ALT) United States $0.026B 0.00
Iterum Therapeutics (ITRM) Ireland $0.024B 0.00
ProPhase Labs (PRPH) United States $0.023B 0.00
Bio-Path Holdings (BPTH) United States $0.022B 0.00
China SXT Pharmaceuticals (SXTC) China $0.021B 0.00
Melinta Therapeutics (MLNT) United States $0.019B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.017B 0.00
Vical (BBI) United States $0.017B 0.00
Heat Biologics (HTBX) United States $0.016B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.016B 0.00
Cyanotech (CYAN) United States $0.015B 0.00
Shineco (TYHT) China $0.014B 0.00
Flex Pharma (SLRX) United States $0.014B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
Regulus Therapeutics (RGLS) United States $0.014B 0.00
VAXART, INC (VXRT) United States $0.013B 0.00
Lipocine (LPCN) United States $0.010B 0.00
HANCOCK JAFFE (HJLI) United States $0.009B 0.00
Achieve Life Sciences (ACHV) United States $0.007B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Hemispherx BioPharma (AIM) United States $0.004B 0.00
Can-Fite Biopharma (CANF) Israel $0.003B 0.00
RXi Pharmaceuticals (PHIO) United States $0.003B 0.00
Midatech Pharma (MTP) United Kingdom $0.002B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.001B 0.00
Onconova Therapeutics (ONTX) United States $0.001B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00